Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step toward finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court last year.

The new plan allows plaintiffs who sued Purdue to opt in to receive their settlement or reserve their right to file a civil suit against the billionaire Sackler family.